BAYRAM, N. N. Et Al. 2023. HER2-Specific Peptide (LTVSPWY) and Antibody (Herceptin) Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study. Pharmaceutics , vol.15, no.3 .

BAYRAM, N. N., Ulu, G. T., Abdulhadi, N. A., Gürdap, S., İŞOĞLU, İ. A., Baran, Y., ... DİNÇER İŞOĞLU, S.(2023). HER2-Specific Peptide (LTVSPWY) and Antibody (Herceptin) Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study. Pharmaceutics , vol.15, no.3.

BAYRAM, NAZENDE Et Al. "HER2-Specific Peptide (LTVSPWY) and Antibody (Herceptin) Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study," Pharmaceutics , vol.15, no.3, 2023

BAYRAM, NAZENDE N. Et Al. "HER2-Specific Peptide (LTVSPWY) and Antibody (Herceptin) Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study." Pharmaceutics , vol.15, no.3, 2023

BAYRAM, N. N. Et Al. (2023) . "HER2-Specific Peptide (LTVSPWY) and Antibody (Herceptin) Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study." Pharmaceutics , vol.15, no.3.

@article{article, author={NAZENDE NUR BAYRAM Et Al. }, title={HER2-Specific Peptide (LTVSPWY) and Antibody (Herceptin) Targeted Core Cross-Linked Micelles for Breast Cancer: A Comparative Study}, journal={Pharmaceutics}, year=2023}